@5epehr @Risnotmean رو ارائه کنن. اما به دلیل انحصار، این اتفاق نمیفته. تحقیق زیر نشون داده که در صورت نبود انحصار، حتی تا ۹۵٪ قیمت دارو ممکنه کاهش پیدا کنه: https://t.co/XcQrt2biby چهار. اینجا ذکر شده که اخیراً قیمت داروهای Orphan دیگه ربطی به هزینههاش ن
The share of the total pharmaceutical market represented by orphan drugs is predicted to increase from 3.3% in 2010 to a peak of 4.6% in 2016 after which it is expected to level off through 2020, #IndiaRareDiseasePolicy @MoHFW_INDIA @drharshvardhan https:/
@matthewherper @VoltaireFMA18 @xia8889 @DietrichMunn @adamfeuerstein It seems the US is not the only country grappling with these issues regarding rare diseases. https://t.co/RGYFeL9kyd https://t.co/gvTypUPdBn https://t.co/vBzVCGvRIX https://t.co/8Vcx
RT @BSBHbyVT: OMPs accounted for 3.3% of the total EU pharma budget in 2010, while pharma only accounts for around 15% of the overall healt…